Combination Therapy for lung cancer treatment is one of the latest, most exciting advances in lung cancer research. Studies of patients being treated with combination therapy show increase in the overall survival rate for lung cancer patients. Combination therapy
...
Biomarker (or Genomic Diagnostic) testing is key in today’s world of precision medicine. Lung cancer biomarker testing is also known as tumor testing, genetic mutation testing, next generation sequencing (NGS) or genomic testing. It looks for changes in the
...
Targeted therapies are a form of personalized medicine that is bringing great hope to lung cancer patients. Targeted therapies have been found to have great benefit and fewer side effects while giving lung cancer patients more options for treatment.
...
Senior Year Disrupted In a Flash In May, 2014, Corey Wood was your typical 22-year old college student. A senior at Cal Berkeley, she was juggling classes, a job, and an internship, all in preparation to graduate and begin
...
Like people, no two lung cancer tumors are the same. Personalized medicine (also known as precision medicine) is the idea of tailoring treatment to each patient. This takes into account both patient and specific tumor characteristics. Instead of using more
...
LCFA’s own Dr. Michael Weitz shares his lung cancer story with the Del Mar Times in the lead up to LCFA’s 7th annual Day at the Races event on July 24, 2016. “This age of targeted therapies and personalized…